Inception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. Inception’s integrated chemistry, biology and DMPK expertise and capabilities coupled with a successful track record have enabled Inception to become an established leader in new company creation.

Executive Leadership

Jeremy Caldwell photo

Jeremy Caldwell, Ph.D.
President and Chief Executive Officer

Richard Glynne photo

Richard Glynne, Ph.D.
Chief Scientific Officer

Shelly Meeusen photo

Shelly Meeusen, Ph.D.
Vice President of Biology

Justin Ernst photo

Justin Ernst, Ph.D.
Executive Director of Chemistry

Dikran Aivazian photo

Dikran Aivazian
Executive Director of Protein Therapeutics

Nancy Brzezniak photo

Nancy Brzezniak
Director of Finance

Peppi Prasit photo

Peppi Prasit, Ph.D.
Scientific Advisor

Scientific Advisory Board

Carolyn Bertozzi photo

Carolyn Bertozzi
Scientific Advisor

Benjamin Cravatt photo

Benjamin F. Cravatt
Scientific Advisor

Nathanael Gray photo

Nathanael S. Gray, Ph.D.
Scientific Advisor

James Wells photo

James A. Wells, Ph.D.
Scientific Advisor